{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:05:40Z","timestamp":1792076740084,"version":"4.4.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Visceral leishmaniasis (VL) is a severe and often fatal form of leishmaniasis caused by <jats:italic>Leishmania donovani<\/jats:italic> in the Indian sub-continent. Post Kala-azar Dermal Leishmaniasis (PKDL) is a late cutaneous manifestation of VL, typically occurring after apparent cure of VL, but sometimes even without a prior history of VL in India. PKDL serves as a significant yet neglected reservoir of infection and plays a crucial role in the transmission of the disease, posing a serious threat to the VL elimination program in the Indian sub-continent. Therefore, the eradication of PKDL should be a priority within the current VL elimination program aimed at achieving a goal of less than 1 case per 10,000 in the population at the district or sub-district levels of VL endemic areas. To accomplish this, a comprehensive understanding of the pathogenesis of PKDL is essential, as well as developing strategies for disease management. This review provides an overview of the current status of diagnosis and treatment options for PKDL, highlighting our current knowledge of the immune responses underlying disease development and progression. Additionally, the review discusses the impact of PKDL on elimination programs and propose strategies to overcome this challenge and achieve the goal of elimination. By addressing the diagnostic and therapeutic gaps, optimizing surveillance and control measures, and implementing effective intervention strategies, it is possible to mitigate the burden of PKDL and facilitate the successful elimination of VL in the Indian sub-continent.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1236952","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:27:09Z","timestamp":1691774829000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination"],"prefix":"10.3389","volume":"14","author":[{"given":"Awnish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasoon","family":"Madhukar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rajneesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhav","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Engwerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002914","article-title":"Immune regulation during chronic visceral leishmaniasis","volume":"8","author":"Faleiro","year":"2014","journal-title":"PloS Negl Trop Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin Trans Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9872095","article-title":"Current visceral leishmaniasis research: a research review to inspire future study","volume":"2018","author":"Bi","year":"2018","journal-title":"BioMed Res Int"},{"key":"B6","volume-title":"Kala-azar elimination programme: report of a WHO consultation of partners","year":"2015"},{"key":"B7","volume-title":"Kala-azar cases and deaths in the country since 2010","year":"2016"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00132-21","article-title":"Utility of blood as the clinical specimen for the molecular diagnosis of post-Kala-Azar dermal leishmaniasis","volume":"59","author":"Dixit","year":"2021","journal-title":"J Clin Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.04925.x","article-title":"Post-kala-azar dermal leishmaniasis: recent developments","volume":"50","author":"Singh","year":"2011","journal-title":"Int J Dermatol"},{"key":"B10","volume-title":"Post-kala-azar dermal leishmaniasis: a manual for case management and control","year":"2012"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155321","article-title":"The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis","volume":"155321","author":"Jafarzadeh","year":"2020","journal-title":"Cytokine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30166-X","article-title":"Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study","volume":"2","author":"Singh","year":"2021","journal-title":"Lancet Microbe"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18069","DOI":"10.1038\/s41598-022-21497-6","article-title":"Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasis","volume":"12","author":"Ghosh","year":"2022","journal-title":"Sci Rep"},{"key":"B14","unstructured":"2023"},{"key":"B15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/ijd.IJD_651_20","article-title":"Epidemiology of post-Kala-Azar dermal leishmaniasis","volume":"66","author":"Ghosh","year":"2021","journal-title":"Indian J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-2424-8","article-title":"Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study","volume":"15","author":"Ramesh","year":"2015","journal-title":"BMC Public Health"},{"key":"B18","article-title":"Kala-azar in India \u2013 progress and challenges towards its elimination as a public health problem","author":"Gill","year":"2021"},{"key":"B19","first-page":"341","article-title":"Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas","volume":"70","author":"Addy","year":"1992","journal-title":"Bull World Health Organ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy891","article-title":"Quantifying the infectiousness of post-kala-azar dermal leishmaniasis toward sand flies","volume":"69","author":"Mondal","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B21","first-page":"295","article-title":"Challenges in the diagnosis of post kala-azar dermal leishmaniasis","volume":"123","author":"Salotra","year":"2006","journal-title":"Indian J Med Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/ijd.IJD_602_20","article-title":"Post kala-azar dermal leishmaniasis: Clinical features and differential diagnosis","volume":"66","author":"Kumar","year":"2021","journal-title":"Indian J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08072.x","article-title":"Postkala-azar dermal leishmaniasis coexisting with borderline tuberculoid leprosy","volume":"157","author":"Bansal","year":"2007","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.01.011","article-title":"Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis","volume":"75","author":"Verma","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/ijd.IJD_311_19","article-title":"Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis","volume":"65","author":"Dixit","year":"2020","journal-title":"Indian J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.3.849-854.2001","article-title":"Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis","volume":"39","author":"Salotra","year":"2001","journal-title":"J Clin Microbiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008221","article-title":"Post kala-azar dermal leishmaniasis: A threat to elimination program","volume":"14","author":"Gedda","year":"2020","journal-title":"PloS Negl Trop Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.4.1777-1778.2004","article-title":"Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal leishmaniasis lesions","volume":"42","author":"Sreenivas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12421","article-title":"Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis","volume":"20","author":"Vallur","year":"2014","journal-title":"Clin Microbiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.11.5249-5255.2004","article-title":"Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity","volume":"42","author":"Mary","year":"2004","journal-title":"J Clin Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2318-8","article-title":"Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection","volume":"17","author":"Verma","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.12.e63","article-title":"Loop-mediated isothermal amplification of DNA","volume":"28","author":"Notomi","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007698","article-title":"Loop-mediated isothermal amplification (LAMP): An advanced molecular point-of-care technique for the detection of Leishmania infection","volume":"13","author":"Nzelu","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-013-0590-0","article-title":"Loop-mediated isothermal amplification (LAMP): recent progress in research and development","volume":"19","author":"Mori","year":"2013","journal-title":"J Infect Chemother"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006922","article-title":"Validation of SYBR green I based closed tube loop mediated isothermal amplification (LAMP) assay and simplified direct-blood-lysis (DBL)-LAMP assay for diagnosis of visceral leishmaniasis (VL)","volume":"12","author":"Dixit","year":"2018","journal-title":"PloS Negl Trop Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000832","article-title":"Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh","volume":"4","author":"Mondal","year":"2010","journal-title":"PloS Negl Trop Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/150746","article-title":"Systematic review into diagnostics for post-kala-azar dermal leishmaniasis (PKDL)","volume":"2013","author":"Adams","year":"2013","journal-title":"J Trop Med"},{"key":"B38","first-page":"619","article-title":"Use of RK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal","volume":"38","author":"Das","year":"2007","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005877","article-title":"Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme","volume":"11","author":"Zijlstra","year":"2017","journal-title":"PloS Negl Trop Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90048-9","article-title":"Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B","volume":"89","author":"Hashim","year":"1995","journal-title":"Trans R Soc Trop Med Hygiene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1179\/136485905X514127","article-title":"Efficacy of liposomal amphotericin B (AmBisome\u00ae) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)","volume":"99","author":"Musa","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy172","article-title":"Safety and effectiveness of short-course amBisome in the treatment of post\u2013kala-azar dermal leishmaniasis: A prospective cohort study in Bangladesh","volume":"67","author":"den Boer","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002864","article-title":"Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh\u2014a case report","volume":"8","author":"Marking","year":"2014","journal-title":"PloS Negl Trop Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_338_20","article-title":"Liposomal amphotericin B is more effective in polymorphic lesions of post kala-azar dermal leishmaniasis","volume":"88","author":"Moulik","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.trstmh.2005.09.015","article-title":"Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine","volume":"100","author":"Sundar","year":"2006","journal-title":"Trans R Soc Trop Med Hygiene"},{"key":"B47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/tmi.12015","article-title":"Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial","volume":"18","author":"Sundar","year":"2013","journal-title":"Trop Med Int Health"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/414378","article-title":"Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis","volume":"2015","author":"Sundar","year":"2015","journal-title":"Sci World J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/ijd.IJD_264_20","article-title":"Therapeutic modalities in post kala-azar dermal leishmaniasis: A systematic review of the effectiveness and safety of the treatment options","volume":"66","author":"Datta","year":"2021","journal-title":"Indian J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-004-0348-9","article-title":"chemotherapy. Challenges and new discoveries in the treatment of leishmaniasis","volume":"10","author":"Singh","year":"2004","journal-title":"J Infect"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1974.01630050058014","article-title":"Amphotericin B therapy in dermal leishmanoid","volume":"109","author":"Yesudian","year":"1974","journal-title":"Arch Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1997.11813179","article-title":"Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis","volume":"91","author":"Thakur","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz486","article-title":"Assessing the efficacy and safety of liposomal amphotericin B and miltefosine in combination for treatment of post kala-azar dermal leishmaniasis","volume":"221","author":"Ramesh","year":"2020","journal-title":"J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32834a8ba1","article-title":"Recent advances in post-kala-azar dermal leishmaniasis","volume":"24","author":"Mondal","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1086\/648727","article-title":"Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh","volume":"50","author":"Rahman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B57","article-title":"PKDL-a drug related phenomenon","volume":"128","author":"Croft","year":"2008","journal-title":"Indian J Med Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05966-11","article-title":"Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India","volume":"50","author":"Pandey","year":"2012","journal-title":"J Clin Microbiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1179\/000349809X12554106963438","article-title":"Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine\u2019]","volume":"103","author":"Kumar","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2009.06.013","article-title":"Host peroxisomal properties are not restored to normal after treatment of visceral leishmaniasis with sodium antimony gluconate","volume":"123","author":"Gupta","year":"2009","journal-title":"Exp Parasitol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10-and TGF-\u03b2-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00089-3","article-title":"High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis","volume":"75","author":"Gasim","year":"2000","journal-title":"Acta tropica"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00468.x","article-title":"High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis","volume":"111","author":"Gasim","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/4.3.270","article-title":"Genetics of murine leishmaniasis","volume":"4","author":"Foote","year":"2005","journal-title":"Briefings Funct Genomics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nrg1832","article-title":"Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis","volume":"7","author":"Lipoldov\u00e1","year":"2006","journal-title":"Nat Rev Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000076678","article-title":"Genetic susceptibility to leishmanial infections: studies in mice and man","volume":"112","author":"Blackwell","year":"1996","journal-title":"Parasitology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364353","article-title":"IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan","volume":"8","author":"Salih","year":"2007","journal-title":"Genes Immunity"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1086\/506624","article-title":"Interferon (IFN)\u2013\u03b3, tumor necrosis factor\u2013\u03b1, interleukin-6, and IFN-\u03b3 receptor 1 are the major immunological determinants associated with post\u2013kala azar dermal leishmaniasis","volume":"194","author":"Ansari","year":"2006","journal-title":"J Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2005.03.035","article-title":"The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role","volume":"66","author":"Ismail","year":"2006","journal-title":"Med Hypotheses"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2001.01047.x","article-title":"Ultraviolet light induced injury: immunological and inflammatory effects","volume":"79","author":"Clydesdale","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152309787580775","article-title":"UV induced skin immunosuppression","volume":"8","author":"Amerio","year":"2009","journal-title":"Anti-Inflamm Anti-Allergy Agents Med Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nri3045","article-title":"Modulation of the immune system by UV radiation: more than just the effects of vitamin D","volume":"11","author":"Hart","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90005-R","article-title":"Immunosuppression by ultraviolet B radiation: initiation by urocanic acid","volume":"13","author":"Noonan","year":"1992","journal-title":"Immunol Today"},{"key":"B74","article-title":"Distorted antigen-presenting function of Langerhans cells induced by tumor necrosis factor alpha via a mechanism that appears different from that induced by ultraviolet B radiation","volume":"8","author":"Simon","year":"1991","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1086\/382135","article-title":"Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure","volume":"189","author":"Mendon\u00e7a","year":"2004","journal-title":"J Infect Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.1.220-226.1993","article-title":"Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host","volume":"61","author":"Aebischer","year":"1993","journal-title":"Infect Immun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.58.824","article-title":"Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) Braziliensis persistence and viability eleven years after antimonial therapy and clinical cure","volume":"58","author":"Schubach","year":"1998","journal-title":"Am J Trop Med hygiene"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2006.09.001","article-title":"Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India","volume":"7","author":"Dey","year":"2007","journal-title":"Infect Genet Evol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00809-15","article-title":"De novo whole-genome sequence and annotation of a Leishmania strain isolated from a case of post-kala-azar dermal leishmaniasis","volume":"3","author":"Gupta","year":"2015","journal-title":"Genome announcements"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1721-0","article-title":"The immunology of post-kala-azar dermal leishmaniasis (PKDL)","volume":"9","author":"Zijlstra","year":"2016","journal-title":"Parasites Vectors"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2005.06.007","article-title":"Insights into CD4+ memory T cells following Leishmania infection","volume":"21","author":"Gollob","year":"2005","journal-title":"Trends Parasitol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(99)00050-4","article-title":"Global control and Leishmania HIV co-infection","volume":"17","author":"Desjeux","year":"1999","journal-title":"Clinics Dermatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol Today"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.393","article-title":"Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis","volume":"130","author":"Ganguly","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<615::AID-PATH466>3.0.CO;2-Z","article-title":"Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile","volume":"189","author":"Ismail","year":"1999","journal-title":"J Pathol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01579.x","article-title":"Lesional T-cell subset in post-kala-azar dermal leishmaniasis","volume":"44","author":"Rathi","year":"2005","journal-title":"Int J Dermatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunologic Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(98)00132-1","article-title":"T-cell response in human leishmaniasis","volume":"65","author":"Kharazmi","year":"1999","journal-title":"Immunol Lett"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04558.x","article-title":"Post-kala-azar dermal leishmaniasis\u2013an overview","volume":"49","author":"Ganguly","year":"2010","journal-title":"Int J Dermatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01854.x","article-title":"Post-kala-azar dermal leishmaniasis\u2013an appraisal","volume":"12","author":"Ramesh","year":"2007","journal-title":"Trop Med Int Health"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1086\/588387","article-title":"Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis","volume":"197","author":"Ganguly","year":"2008","journal-title":"J Infect Dis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10875-015-0215-8","article-title":"Decreased frequency and secretion of CD26 promotes disease progression in Indian Post Kala-azar dermal leishmaniasis","volume":"36","author":"Mukherjee","year":"2016","journal-title":"J Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir551","article-title":"Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis","volume":"204","author":"Mukhopadhyay","year":"2011","journal-title":"J Infect Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2008.05.015","article-title":"Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis","volume":"102","author":"Ansari","year":"2008","journal-title":"Trans R Soc Trop Med Hygiene"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363977","article-title":"Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1","volume":"4","author":"Mohamed","year":"2003","journal-title":"Genes Immun"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001171","article-title":"Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients","volume":"5","author":"Katara","year":"2011","journal-title":"PloS Negl Trop Dis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001703","article-title":"Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL)","volume":"6","author":"Katara","year":"2012","journal-title":"PloS Negl Trop Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12170","article-title":"Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation","volume":"259","author":"Smigiel","year":"2014","journal-title":"Immunol Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062175","article-title":"Conventional T-bet+ Foxp3\u2013 Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection","volume":"204","author":"Jankovic","year":"2007","journal-title":"J Exp Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835711","article-title":"T lymphocyte exhaustion during human and experimental visceral leishmaniasis","volume":"13","author":"Costa-Madeira","year":"2022","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061886","article-title":"CD4+ CD25\u2013 Foxp3\u2013 Th1 cells are the source of IL-10\u2013mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+ CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nyl\u00e9n","year":"2007","journal-title":"J Exp Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008363","article-title":"Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination","volume":"14","author":"Singh","year":"2020","journal-title":"PloS Negl Trop Dis"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007798","article-title":"Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site","volume":"13","author":"Hasker","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30140-2","article-title":"Elimination of visceral leishmaniasis on the Indian subcontinent","volume":"16","author":"Singh","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.641632","article-title":"Towards a sustainable vector-control strategy in the post kala-azar elimination era","volume":"11","author":"Garlapati","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/diagnostics12030670","article-title":"Diagnosis of visceral leishmaniasis in an elimination setting: A validation study of the diagnostic algorithm in India","volume":"12","author":"Cloots","year":"2022","journal-title":"Diagnostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1236952\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:27:17Z","timestamp":1691774837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1236952\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":108,"alternative-id":["10.3389\/fimmu.2023.1236952"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1236952","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"article-number":"1236952"}}